Optos PLC

Optos PLC of Dunfermline, UK, has received FDA approval for its P200MA retinal imaging device. The instrument, which takes a quarter of a second to scan approximately 80 percent of the retina, is expected to aid in the detection of glaucoma, diabetes and high blood pressure, among other diseases. The technology is already being tested in the US.





LATEST NEWS

• Photronics Makes Board Appointment: People in the News: 12/26/24
  Dec 26, 2024
• Tiny Fiber Photoacoustic Spectrometer Enables Fast, Minimally Invasive Analysis
  Dec 26, 2024
• Low-Cost 3D-Printed Device Generates Vortex Beams
  Dec 24, 2024
• Hybrid Material Achieves Fast, Stable Phosphorescent Emission for OLEDs
  Dec 24, 2024
• Quantum Teleportation Demonstrated Over Busy Internet Cables
  Dec 23, 2024
• Teledyne Space Imaging Selected to Build Payload for LISA Space
  Dec 23, 2024
• LLNL and Starris: Optimax Space Systems Partner on Monolithic Telescope Tech
  Dec 20, 2024
• Civan Lasers Launches U.S. Demonstration Labs: Week in Brief: 12/20/24
  Dec 20, 2024